tiprankstipranks
Trending News
More News >
Acro Biomedical Co Ltd (ACBM)
OTHER OTC:ACBM
US Market

Acro Biomedical Co (ACBM) Income Statement

Compare
11 Followers

Acro Biomedical Co Income Statement

Last quarter (Q4 2025), Acro Biomedical Co's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Acro Biomedical Co's net income was $42.53K. See Acro Biomedical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 658.50K$ 1.20M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 140.50K$ 259.50K
Operating Expenses
$ 154.02K$ 37.96K$ 8.80M$ 16.01M$ 7.95M
Depreciation and Amortization
$ 0.00$ 0.00$ 8.79M$ 0.00$ 7.69M
EBITDA
$ -154.02K$ -37.96K$ 0.00$ -15.87M$ 0.00
Operating Income
$ -154.02K$ -37.96K$ -8.80M$ -15.87M$ -7.69M
Other Income/Expenses
$ 52.88K$ -4.34K$ -3.21K$ -1.71K$ -4.25K
Pretax Income
$ -101.15K$ -42.30K$ -8.81M$ -15.87M$ -7.70M
Net Income
$ -101.15K$ -42.30K$ -8.81M$ -15.87M$ -7.70M
Per Share Metrics
Basic EPS
$ >-0.01$ 0.00$ -0.15$ -0.26$ -0.14
Diluted EPS
$ >-0.01$ 0.00$ -0.15$ -0.26$ -0.14
Weighted Average Shares Outstanding
60.04M 60.04M 60.04M 60.04M 53.84M
Weighted Average Shares Outstanding (Diluted)
60.04M 60.04M 60.04M 60.04M 53.84M
Currency in USD

Acro Biomedical Co Earnings and Revenue History